These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 22487820
1. [Identification of a mutation in exon 4 of apolipoprotein E gene in a family affected with lipoprotein glomerulopathy]. Han HL, Lin S, Sun LS, Zhang P, Zhai DP. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):141-4. PubMed ID: 22487820 [Abstract] [Full Text] [Related]
2. Plasma level and genetic variation of apolipoprotein E in patients with lipoprotein glomerulopathy. Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Zhou H, Li LS. Chin Med J (Engl); 2005 Apr 05; 118(7):555-60. PubMed ID: 15820086 [Abstract] [Full Text] [Related]
3. [A 3-amino acid deletion of apolipoprotein E found in 3 Chinese lipoprotein glomerulopathy patients]. Chen YQ, Zhang H, Zhu SL, Zou WZ, Wang M, Liu ZS, Wang HY. Zhonghua Yi Xue Za Zhi; 2003 May 10; 83(9):774-7. PubMed ID: 12899757 [Abstract] [Full Text] [Related]
4. A novel apolipoprotein E mutation caused by a five amino acid deletion in a Chinese family with lipoprotein glomerulopathy: a case report. Xie W, Xie Y, Lin Z, Xu X, Zhang Y. Diagn Pathol; 2019 May 15; 14(1):41. PubMed ID: 31092271 [Abstract] [Full Text] [Related]
5. A novel 18-amino acid deletion in apolipoprotein E associated with lipoprotein glomerulopathy. Ando M, Sasaki J, Hua H, Matsunaga A, Uchida K, Jou K, Oikawa S, Saito T, Nihei H. Kidney Int; 1999 Oct 15; 56(4):1317-23. PubMed ID: 10504484 [Abstract] [Full Text] [Related]
6. A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Matsunaga A, Sasaki J, Komatsu T, Kanatsu K, Tsuji E, Moriyama K, Koga T, Arakawa K, Oikawa S, Saito T, Kita T, Doi T. Kidney Int; 1999 Aug 15; 56(2):421-7. PubMed ID: 10432380 [Abstract] [Full Text] [Related]
7. A founder haplotype of APOE-Sendai mutation associated with lipoprotein glomerulopathy. Toyota K, Hashimoto T, Ogino D, Matsunaga A, Ito M, Masakane I, Degawa N, Sato H, Shirai S, Umetsu K, Tamiya G, Saito T, Hayasaka K. J Hum Genet; 2013 May 15; 58(5):254-8. PubMed ID: 23407349 [Abstract] [Full Text] [Related]
8. A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy. Bomback AS, Song H, D'Agati VD, Cohen SD, Neal A, Appel GB, Rovin BH. Nephrol Dial Transplant; 2010 Oct 15; 25(10):3442-6. PubMed ID: 20624773 [Abstract] [Full Text] [Related]
9. A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy. Mitani A, Ishigami M, Watase K, Minakata T, Yamamura T. J Atheroscler Thromb; 2011 Oct 15; 18(6):531-5. PubMed ID: 21325775 [Abstract] [Full Text] [Related]
10. Clinicopathological and genetic characteristics in Chinese patients with lipoprotein glomerulopathy. Zhang B, Liu ZH, Zeng CH, Zheng JM, Chen HP, Li LS. J Nephrol; 2008 Oct 15; 21(1):110-7. PubMed ID: 18264944 [Abstract] [Full Text] [Related]
11. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy. Luo B, Huang F, Liu Q, Li X, Chen W, Zhou SF, Yu X. Am J Nephrol; 2008 Oct 15; 28(2):347-53. PubMed ID: 18046082 [Abstract] [Full Text] [Related]
12. The Novel Apolipoprotein E Mutation ApoE Chengdu (c.518T>C, p.L173P) in a Chinese Patient with Lipoprotein Glomerulopathy. Wu H, Yang Y, Hu Z. J Atheroscler Thromb; 2018 Aug 01; 25(8):733-740. PubMed ID: 29398675 [Abstract] [Full Text] [Related]
13. Impact of lipoprotein glomerulopathy on the relationship between lipids and renal diseases. Saito T, Matsunaga A, Oikawa S. Am J Kidney Dis; 2006 Feb 01; 47(2):199-211. PubMed ID: 16431249 [Abstract] [Full Text] [Related]
14. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy. Hagiwara M, Yamagata K, Matsunaga T, Arakawa Y, Usui J, Shimizu Y, Aita K, Nagata M, Koyama A, Zhang B, Mastunaga A, Saku K, Saito T. Nephrol Dial Transplant; 2008 Jan 01; 23(1):381-4. PubMed ID: 17967799 [No Abstract] [Full Text] [Related]
15. [Apolipoprotein E polymorphism and plasma lipid, lipoprotein, apolipoprotein levels in 291 children of Changsha]. Xiang W, Zhao S, Peng D. Hunan Yi Ke Da Xue Xue Bao; 1999 Jan 01; 24(3):232-6. PubMed ID: 12016791 [Abstract] [Full Text] [Related]
16. A splice junction mutation causes deletion of a 72-base exon from the mRNA for lysosomal acid lipase in a patient with cholesteryl ester storage disease. Klima H, Ullrich K, Aslanidis C, Fehringer P, Lackner KJ, Schmitz G. J Clin Invest; 1993 Dec 01; 92(6):2713-8. PubMed ID: 8254026 [Abstract] [Full Text] [Related]
17. Etiological significance of apolipoprotein E mutations in lipoprotein glomerulopathy. Saito T, Ishigaki Y, Oikawa S, Yamamoto TT. Trends Cardiovasc Med; 2002 Feb 01; 12(2):67-70. PubMed ID: 11852253 [Abstract] [Full Text] [Related]
18. Common apolipoprotein E gene mutations contribute to lipoprotein glomerulopathy in China. Han J, Pan Y, Chen Y, Li X, Xing G, Shi J, Hou P, Zhang H, Wang H. Nephron Clin Pract; 2010 Feb 01; 114(4):c260-7. PubMed ID: 20090368 [Abstract] [Full Text] [Related]
19. Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy. Konishi K, Saruta T, Kuramochi S, Oikawa S, Saito T, Han H, Matsunaga A, Sasaki J. Nephron; 1999 Feb 01; 83(3):214-8. PubMed ID: 10529627 [Abstract] [Full Text] [Related]
20. Lipoprotein glomerulopathy associated with the Osaka/Kurashiki APOE variant: two cases identified in Latin America. da Silveira-Neto JN, de Oliveira Ahn GJ, de Menezes Neves PDM, Baptista VAF, de Almeida Araújo S, Wanderley DC, Watanabe A, Watanabe EH, Murai NM, Bertollo EMG, Vieira-Neto OM, Dantas M, de Antônio SR, Costa RS, Baptista MASF, Moysés-Neto M, Onuchic LF. Diagn Pathol; 2021 Jul 26; 16(1):65. PubMed ID: 34311745 [Abstract] [Full Text] [Related] Page: [Next] [New Search]